QRxPharma and China Aoxing Pharmaceutical Co. (CAXG.OB) Partner to Develop New Drug(s)
QRxPharma Limited (QRX), a pharmaceutical developer of central nervous system (CNS) disorder and pain management drugs with multiple products in early and late-stage clinical trials, and China Aoxing Pharmaceutical Company (CAXG), an established pharmaceutical company with the largest and most advanced manufacturing facility in China, announced a strategic alliance today. The two companies will work hand in hand to develop a new intravenous drug based on QRX’s proprietary oxycodone/morphine Dual-Opioid™ technology. The new drug, known as MoxDuo®IV, is designed for moderate to severe pain. Funding for development of the new drug will be provided by CAXG, which will then have…